Global New Drug Delivery Systems Market 2025-2029

Best Price Guarantee	Length	Publisher	Published Date	SKU
from $2,500	221 Pages	TechNavio	April, 2025	INF19954011

Best Price Guarantee
Price	from $2,500
Length	221 Pages
Publisher	TechNavio
Published Date	April, 2025
SKU	INF19954011

New Drug Delivery Systems Market 2025-2029

The new drug delivery systems market is forecasted to grow by USD 59.4 bn during 2024-2029, accelerating at a CAGR of 4.6% during the forecast period. The report on the new drug delivery systems market provides a holistic analysis, market size and forecast, trends, growth drivers, and challenges, as well as vendor analysis covering around 25 vendors.

The report offers an up-to-date analysis regarding the current market scenario, the latest trends and drivers, and the overall market environment. The market is driven by rising prevalence of chronic diseases, growth in biologics market, and digitalization in healthcare system.

The study was conducted using an objective combination of primary and secondary information including inputs from key participants in the industry. The report contains a comprehensive market size data, segment with regional analysis and vendor landscape in addition to an analysis of the key companies. Reports have historic and forecast data.

Technavio's new drug delivery systems market is segmented as below:

By Application

Oncology
Neurology
Cardiology
Diabetes
Others

By Route Of Administration

Oral drug delivery systems
Injectable drug delivery systems
Pulmonary drug delivery systems
Transdermal drug delivery systems
Others

By Method

Targeted drug delivery systems
Controlled drug delivery systems
Modulated drug delivery systems

By Geographical Landscape

North America
Europe
Asia
Rest of World (ROW)

This study identifies the rising prevalence of chronic diseases as one of the prime reasons driving the new drug delivery systems market growth during the next few years. Also, growth in biologics market and digitalization in healthcare system will lead to sizable demand in the market.

The report on the new drug delivery systems market covers the following areas:

New Drug Delivery Systems Market sizing
New Drug Delivery Systems Market forecast
New Drug Delivery Systems Market industry analysis

The robust vendor analysis is designed to help clients improve their market position, and in line with this, this report provides a detailed analysis of several leading new drug delivery systems market vendors that include Abbott Laboratories, Amgen Inc., Antares Pharma Inc., AstraZeneca Plc, Baxter International Inc., Becton Dickinson and Co., Boehringer Ingelheim International GmbH, Eli Lilly and Co., F. Hoffmann La Roche Ltd., Gerresheimer AG, Gilead Sciences Inc., Kindeva Drug Delivery L.P., Medtronic Plc, Merck KGaA, Nemera Group, Pfizer Inc., Sanofi SA, Teva Pharmaceutical Industries Ltd., West Pharmaceutical Services Inc., and Ypsomed Holding AG. Also, the new drug delivery systems market analysis report includes information on upcoming trends and challenges that will influence market growth. This is to help companies strategize and leverage all forthcoming growth opportunities.

The publisher presents a detailed picture of the market by the way of study, synthesis, and summation of data from multiple sources by an analysis of key parameters such as profit, pricing, competition, and promotions. It presents various market facets by identifying the key industry influencers. The data presented is comprehensive, reliable, and a result of extensive primary and secondary research. The market research reports provide a complete competitive landscape and an in-depth vendor selection methodology and analysis using qualitative and quantitative research to forecast accurate market growth.

1 Executive Summary: 1.1 Market overview; Executive Summary - Chart on Market Overview; Executive Summary - Data Table on Market Overview; Executive Summary - Chart on Global Market Characteristics; Executive Summary - Chart on Market By Geographical Landscape; Executive Summary - Chart on Market Segmentation by Application; Executive Summary - Chart on Market Segmentation by Route of Administration; Executive Summary - Chart on Market Segmentation by Method; Executive Summary - Chart on Incremental Growth; Executive Summary - Data Table on Incremental Growth; Executive Summary - Chart on Company Market Positioning
2 Technavio Analysis: 2.1 Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria; Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria; 2.2 Criticality of inputs and Factors of differentiation; Overview on criticality of inputs and factors of differentiation; 2.3 Factors of disruption; Overview on factors of disruption; 2.4 Impact of drivers and challenges; Impact of drivers and challenges in 2024 and 2029
3 Market Landscape: 3.1 Market ecosystem; Parent Market; Data Table on - Parent Market; 3.2 Market characteristics; Market characteristics analysis; 3.3 Value chain analysis; Value chain analysis
4 Market Sizing: 4.1 Market definition; Offerings of companies included in the market definition; 4.2 Market segment analysis; Market segments; 4.3 Market size 2024; 4.4 Market outlook: Forecast for 2024-2029; Chart on Global - Market size and forecast 2024-2029 ($ billion); Data Table on Global - Market size and forecast 2024-2029 ($ billion); Chart on Global Market: Year-over-year growth 2024-2029 (%); Data Table on Global Market: Year-over-year growth 2024-2029 (%)
5 Historic Market Size: 5.1 Global New Drug Delivery Systems Market 2019 - 2023; Historic Market Size - Data Table on Global New Drug Delivery Systems Market 2019 - 2023 ($ billion); 5.2 Application segment analysis 2019 - 2023; Historic Market Size - Application Segment 2019 - 2023 ($ billion); 5.3 Route of Administration segment analysis 2019 - 2023; Historic Market Size - Route of Administration Segment 2019 - 2023 ($ billion); 5.4 Method segment analysis 2019 - 2023; Historic Market Size - Method Segment 2019 - 2023 ($ billion); 5.5 Geography segment analysis 2019 - 2023; Historic Market Size - Geography Segment 2019 - 2023 ($ billion); 5.6 Country segment analysis 2019 - 2023; Historic Market Size - Country Segment 2019 - 2023 ($ billion)
6 Qualitative Analysis: 6.1 Impact of AI in the Global New Drug Delivery Systems Market
7 Five Forces Analysis: 7.1 Five forces summary; Five forces analysis - Comparison between 2024 and 2029; 7.2 Bargaining power of buyers; Bargaining power of buyers - Impact of key factors 2024 and 2029; 7.3 Bargaining power of suppliers; Bargaining power of suppliers - Impact of key factors in 2024 and 2029; 7.4 Threat of new entrants; Threat of new entrants - Impact of key factors in 2024 and 2029; 7.5 Threat of substitutes; Threat of substitutes - Impact of key factors in 2024 and 2029; 7.6 Threat of rivalry; Threat of rivalry - Impact of key factors in 2024 and 2029; 7.7 Market condition; Chart on Market condition - Five forces 2024 and 2029
8 Market Segmentation by Application: 8.1 Market segments; Chart on Application - Market share 2024-2029 (%); Data Table on Application - Market share 2024-2029 (%); 8.2 Comparison by Application; Chart on Comparison by Application; Data Table on Comparison by Application; 8.3 Oncology - Market size and forecast 2024-2029; Chart on Oncology - Market size and forecast 2024-2029 ($ billion); Data Table on Oncology - Market size and forecast 2024-2029 ($ billion); Chart on Oncology - Year-over-year growth 2024-2029 (%); Data Table on Oncology - Year-over-year growth 2024-2029 (%); 8.4 Neurology - Market size and forecast 2024-2029; Chart on Neurology - Market size and forecast 2024-2029 ($ billion); Data Table on Neurology - Market size and forecast 2024-2029 ($ billion); Chart on Neurology - Year-over-year growth 2024-2029 (%); Data Table on Neurology - Year-over-year growth 2024-2029 (%); 8.5 Cardiology - Market size and forecast 2024-2029; Chart on Cardiology - Market size and forecast 2024-2029 ($ billion); Data Table on Cardiology - Market size and forecast 2024-2029 ($ billion); Chart on Cardiology - Year-over-year growth 2024-2029 (%); Data Table on Cardiology - Year-over-year growth 2024-2029 (%); 8.6 Diabetes - Market size and forecast 2024-2029; Chart on Diabetes - Market size and forecast 2024-2029 ($ billion); Data Table on Diabetes - Market size and forecast 2024-2029 ($ billion); Chart on Diabetes - Year-over-year growth 2024-2029 (%); Data Table on Diabetes - Year-over-year growth 2024-2029 (%); 8.7 Others - Market size and forecast 2024-2029; Chart on Others - Market size and forecast 2024-2029 ($ billion); Data Table on Others - Market size and forecast 2024-2029 ($ billion); Chart on Others - Year-over-year growth 2024-2029 (%); Data Table on Others - Year-over-year growth 2024-2029 (%); 8.8 Market opportunity by Application; Market opportunity by Application ($ billion); Data Table on Market opportunity by Application ($ billion)
9 Market Segmentation by Route of Administration: 9.1 Market segments; Chart on Route of Administration - Market share 2024-2029 (%); Data Table on Route of Administration - Market share 2024-2029 (%); 9.2 Comparison by Route of Administration; Chart on Comparison by Route of Administration; Data Table on Comparison by Route of Administration; 9.3 Oral drug delivery systems - Market size and forecast 2024-2029; Chart on Oral drug delivery systems - Market size and forecast 2024-2029 ($ billion); Data Table on Oral drug delivery systems - Market size and forecast 2024-2029 ($ billion); Chart on Oral drug delivery systems - Year-over-year growth 2024-2029 (%); Data Table on Oral drug delivery systems - Year-over-year growth 2024-2029 (%); 9.4 Injectable drug delivery systems - Market size and forecast 2024-2029; Chart on Injectable drug delivery systems - Market size and forecast 2024-2029 ($ billion); Data Table on Injectable drug delivery systems - Market size and forecast 2024-2029 ($ billion); Chart on Injectable drug delivery systems - Year-over-year growth 2024-2029 (%); Data Table on Injectable drug delivery systems - Year-over-year growth 2024-2029 (%); 9.5 Pulmonary drug delivery systems - Market size and forecast 2024-2029; Chart on Pulmonary drug delivery systems - Market size and forecast 2024-2029 ($ billion); Data Table on Pulmonary drug delivery systems - Market size and forecast 2024-2029 ($ billion); Chart on Pulmonary drug delivery systems - Year-over-year growth 2024-2029 (%); Data Table on Pulmonary drug delivery systems - Year-over-year growth 2024-2029 (%); 9.6 Transdermal drug delivery systems - Market size and forecast 2024-2029; Chart on Transdermal drug delivery systems - Market size and forecast 2024-2029 ($ billion); Data Table on Transdermal drug delivery systems - Market size and forecast 2024-2029 ($ billion); Chart on Transdermal drug delivery systems - Year-over-year growth 2024-2029 (%); Data Table on Transdermal drug delivery systems - Year-over-year growth 2024-2029 (%); 9.7 Others - Market size and forecast 2024-2029; Chart on Others - Market size and forecast 2024-2029 ($ billion); Data Table on Others - Market size and forecast 2024-2029 ($ billion); Chart on Others - Year-over-year growth 2024-2029 (%); Data Table on Others - Year-over-year growth 2024-2029 (%); 9.8 Market opportunity by Route of Administration; Market opportunity by Route of Administration ($ billion); Data Table on Market opportunity by Route of Administration ($ billion); 10 Market Segmentation by Method; 10.1 Market segments; Chart on Method - Market share 2024-2029 (%); Data Table on Method - Market share 2024-2029 (%); 10.2 Comparison by Method; Chart on Comparison by Method; Data Table on Comparison by Method; 10.3 Targeted drug delivery systems - Market size and forecast 2024-2029; Chart on Targeted drug delivery systems - Market size and forecast 2024-2029 ($ billion); Data Table on Targeted drug delivery systems - Market size and forecast 2024-2029 ($ billion); Chart on Targeted drug delivery systems - Year-over-year growth 2024-2029 (%); Data Table on Targeted drug delivery systems - Year-over-year growth 2024-2029 (%); 10.4 Controlled drug delivery systems - Market size and forecast 2024-2029; Chart on Controlled drug delivery systems - Market size and forecast 2024-2029 ($ billion); Data Table on Controlled drug delivery systems - Market size and forecast 2024-2029 ($ billion); Chart on Controlled drug delivery systems - Year-over-year growth 2024-2029 (%); Data Table on Controlled drug delivery systems - Year-over-year growth 2024-2029 (%); 10.5 Modulated drug delivery systems - Market size and forecast 2024-2029; Chart on Modulated drug delivery systems - Market size and forecast 2024-2029 ($ billion); Data Table on Modulated drug delivery systems - Market size and forecast 2024-2029 ($ billion); Chart on Modulated drug delivery systems - Year-over-year growth 2024-2029 (%); Data Table on Modulated drug delivery systems - Year-over-year growth 2024-2029 (%); 10.6 Market opportunity by Method; Market opportunity by Method ($ billion); Data Table on Market opportunity by Method ($ billion); 11 Customer Landscape; 11.1 Customer landscape overview; Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria; 12 Geographic Landscape; 12.1 Geographic segmentation; Chart on Market share By Geographical Landscape 2024-2029 (%); Data Table on Market share By Geographical Landscape 2024-2029 (%); 12.2 Geographic comparison; Chart on Geographic comparison; Data Table on Geographic comparison; 12.3 North America - Market size and forecast 2024-2029; Chart on North America - Market size and forecast 2024-2029 ($ billion); Data Table on North America - Market size and forecast 2024-2029 ($ billion); Chart on North America - Year-over-year growth 2024-2029 (%); Data Table on North America - Year-over-year growth 2024-2029 (%); 12.4 Europe - Market size and forecast 2024-2029; Chart on Europe - Market size and forecast 2024-2029 ($ billion); Data Table on Europe - Market size and forecast 2024-2029 ($ billion); Chart on Europe - Year-over-year growth 2024-2029 (%); Data Table on Europe - Year-over-year growth 2024-2029 (%); 12.5 Asia - Market size and forecast 2024-2029; Chart on Asia - Market size and forecast 2024-2029 ($ billion); Data Table on Asia - Market size and forecast 2024-2029 ($ billion); Chart on Asia - Year-over-year growth 2024-2029 (%); Data Table on Asia - Year-over-year growth 2024-2029 (%); 12.6 Rest of World (ROW) - Market size and forecast 2024-2029; Chart on Rest of World (ROW) - Market size and forecast 2024-2029 ($ billion); Data Table on Rest of World (ROW) - Market size and forecast 2024-2029 ($ billion); Chart on Rest of World (ROW) - Year-over-year growth 2024-2029 (%); Data Table on Rest of World (ROW) - Year-over-year growth 2024-2029 (%); 12.7 US - Market size and forecast 2024-2029; Chart on US - Market size and forecast 2024-2029 ($ billion); Data Table on US - Market size and forecast 2024-2029 ($ billion); Chart on US - Year-over-year growth 2024-2029 (%); Data Table on US - Year-over-year growth 2024-2029 (%); 12.8 Germany - Market size and forecast 2024-2029; Chart on Germany - Market size and forecast 2024-2029 ($ billion); Data Table on Germany - Market size and forecast 2024-2029 ($ billion); Chart on Germany - Year-over-year growth 2024-2029 (%); Data Table on Germany - Year-over-year growth 2024-2029 (%); 12.9 China - Market size and forecast 2024-2029; Chart on China - Market size and forecast 2024-2029 ($ billion); Data Table on China - Market size and forecast 2024-2029 ($ billion); Chart on China - Year-over-year growth 2024-2029 (%); Data Table on China - Year-over-year growth 2024-2029 (%); 12.10 Canada - Market size and forecast 2024-2029; Chart on Canada - Market size and forecast 2024-2029 ($ billion); Data Table on Canada - Market size and forecast 2024-2029 ($ billion); Chart on Canada - Year-over-year growth 2024-2029 (%); Data Table on Canada - Year-over-year growth 2024-2029 (%); 12.11 Japan - Market size and forecast 2024-2029; Chart on Japan - Market size and forecast 2024-2029 ($ billion); Data Table on Japan - Market size and forecast 2024-2029 ($ billion); Chart on Japan - Year-over-year growth 2024-2029 (%); Data Table on Japan - Year-over-year growth 2024-2029 (%); 12.12 UK - Market size and forecast 2024-2029; Chart on UK - Market size and forecast 2024-2029 ($ billion); Data Table on UK - Market size and forecast 2024-2029 ($ billion); Chart on UK - Year-over-year growth 2024-2029 (%); Data Table on UK - Year-over-year growth 2024-2029 (%); 12.13 France - Market size and forecast 2024-2029; Chart on France - Market size and forecast 2024-2029 ($ billion); Data Table on France - Market size and forecast 2024-2029 ($ billion); Chart on France - Year-over-year growth 2024-2029 (%); Data Table on France - Year-over-year growth 2024-2029 (%); 12.14 India - Market size and forecast 2024-2029; Chart on India - Market size and forecast 2024-2029 ($ billion); Data Table on India - Market size and forecast 2024-2029 ($ billion); Chart on India - Year-over-year growth 2024-2029 (%); Data Table on India - Year-over-year growth 2024-2029 (%); 12.15 Italy - Market size and forecast 2024-2029; Chart on Italy - Market size and forecast 2024-2029 ($ billion); Data Table on Italy - Market size and forecast 2024-2029 ($ billion); Chart on Italy - Year-over-year growth 2024-2029 (%); Data Table on Italy - Year-over-year growth 2024-2029 (%); 12.16 South Korea - Market size and forecast 2024-2029; Chart on South Korea - Market size and forecast 2024-2029 ($ billion); Data Table on South Korea - Market size and forecast 2024-2029 ($ billion); Chart on South Korea - Year-over-year growth 2024-2029 (%); Data Table on South Korea - Year-over-year growth 2024-2029 (%); 12.17 Market opportunity By Geographical Landscape; Market opportunity By Geographical Landscape ($ billion); Data Tables on Market opportunity By Geographical Landscape ($ billion); 13 Drivers, Challenges, and Opportunity/Restraints; 13.1 Market drivers; 13.2 Market challenges; 13.3 Impact of drivers and challenges; Impact of drivers and challenges in 2024 and 2029; 13.4 Market opportunities/restraints; 14 Competitive Landscape; 14.1 Overview; 14.2 Competitive Landscape; Overview on criticality of inputs and factors of differentiation; 14.3 Landscape disruption; Overview on factors of disruption; 14.4 Industry risks; Impact of key risks on business; 15 Competitive Analysis; 15.1 Companies profiled; Companies covered; 15.2 Company ranking index; Company ranking index; 15.3 Market positioning of companies; Matrix on companies position and classification; 15.4 Abbott Laboratories; Abbott Laboratories - Overview; Abbott Laboratories - Business segments; Abbott Laboratories - Key news; Abbott Laboratories - Key offerings; Abbott Laboratories - Segment focus; SWOT; 15.5 Amgen Inc.; Amgen Inc. - Overview; Amgen Inc. - Product / Service; Amgen Inc. - Key news; Amgen Inc. - Key offerings; SWOT; 15.6 Antares Pharma Inc.; Antares Pharma Inc. - Overview; Antares Pharma Inc. - Product / Service; Antares Pharma Inc. - Key offerings; SWOT; 15.7 AstraZeneca Plc; AstraZeneca Plc - Overview; AstraZeneca Plc - Product / Service; AstraZeneca Plc - Key news; AstraZeneca Plc - Key offerings; SWOT; 15.8 Baxter International Inc.; Baxter International Inc. - Overview; Baxter International Inc. - Business segments; Baxter International Inc. - Key news; Baxter International Inc. - Key offerings; Baxter International Inc. - Segment focus; SWOT; 15.9 Becton Dickinson and Co.; Becton Dickinson and Co. - Overview; Becton Dickinson and Co. - Business segments; Becton Dickinson and Co. - Key news; Becton Dickinson and Co. - Key offerings; Becton Dickinson and Co. - Segment focus; SWOT; 15.10 Boehringer Ingelheim International GmbH; Boehringer Ingelheim International GmbH - Overview; Boehringer Ingelheim International GmbH - Product / Service; Boehringer Ingelheim International GmbH - Key news; Boehringer Ingelheim International GmbH - Key offerings; SWOT; 15.11 F. Hoffmann La Roche Ltd.; F. Hoffmann La Roche Ltd. - Overview; F. Hoffmann La Roche Ltd. - Business segments; F. Hoffmann La Roche Ltd. - Key news; F. Hoffmann La Roche Ltd. - Key offerings; F. Hoffmann La Roche Ltd. - Segment focus; SWOT; 15.12 Gerresheimer AG; Gerresheimer AG - Overview; Gerresheimer AG - Business segments; Gerresheimer AG - Key news; Gerresheimer AG - Key offerings; Gerresheimer AG - Segment focus; SWOT; 15.13 Kindeva Drug Delivery L.P.; Kindeva Drug Delivery L.P. - Overview; Kindeva Drug Delivery L.P. - Product / Service; Kindeva Drug Delivery L.P. - Key offerings; SWOT; 15.14 Medtronic Plc; Medtronic Plc - Overview; Medtronic Plc - Business segments; Medtronic Plc - Key news; Medtronic Plc - Key offerings; Medtronic Plc - Segment focus; SWOT; 15.15 Nemera Group; Nemera Group - Overview; Nemera Group - Product / Service; Nemera Group - Key offerings; SWOT; 15.16 Pfizer Inc.; Pfizer Inc. - Overview; Pfizer Inc. - Product / Service; Pfizer Inc. - Key news; Pfizer Inc. - Key offerings; SWOT; 15.17 West Pharmaceutical Services Inc.; West Pharmaceutical Services Inc. - Overview; West Pharmaceutical Services Inc. - Business segments; West Pharmaceutical Services Inc. - Key offerings; West Pharmaceutical Services Inc. - Segment focus; SWOT; 15.18 Ypsomed Holding AG; Ypsomed Holding AG - Overview; Ypsomed Holding AG - Business segments; Ypsomed Holding AG - Key offerings; Ypsomed Holding AG - Segment focus; SWOT; 16 Appendix; 16.1 Scope of the report; 16.2 Inclusions and exclusions checklist; Inclusions checklist; Exclusions checklist; 16.3 Currency conversion rates for US$; Currency conversion rates for US$; 16.4 Research methodology; Research methodology; 16.5 Data procurement; Information sources; 16.6 Data validation; Data validation; 16.7 Validation techniques employed for market sizing; Validation techniques employed for market sizing; 16.8 Data synthesis; Data synthesis; 16.9 360 degree market analysis; 360 degree market analysis; 16.10 List of abbreviations; List of abbreviations
Exhibits:: Exhibits1: Executive Summary - Chart on Market Overview; Exhibits2: Executive Summary - Data Table on Market Overview; Exhibits3: Executive Summary - Chart on Global Market Characteristics; Exhibits4: Executive Summary - Chart on Market By Geographical Landscape; Exhibits5: Executive Summary - Chart on Market Segmentation by Application; Exhibits6: Executive Summary - Chart on Market Segmentation by Route of Administration; Exhibits7: Executive Summary - Chart on Market Segmentation by Method; Exhibits8: Executive Summary - Chart on Incremental Growth; Exhibits9: Executive Summary - Data Table on Incremental Growth; Exhibits10: Executive Summary - Chart on Company Market Positioning; Exhibits11: Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria; Exhibits12: Overview on criticality of inputs and factors of differentiation; Exhibits13: Overview on factors of disruption; Exhibits14: Impact of drivers and challenges in 2024 and 2029; Exhibits15: Parent Market; Exhibits16: Data Table on - Parent Market; Exhibits17: Market characteristics analysis; Exhibits18: Value chain analysis; Exhibits19: Offerings of companies included in the market definition; Exhibits20: Market segments; Exhibits21: Chart on Global - Market size and forecast 2024-2029 ($ billion); Exhibits22: Data Table on Global - Market size and forecast 2024-2029 ($ billion); Exhibits23: Chart on Global Market: Year-over-year growth 2024-2029 (%); Exhibits24: Data Table on Global Market: Year-over-year growth 2024-2029 (%); Exhibits25: Historic Market Size - Data Table on Global New Drug Delivery Systems Market 2019 - 2023 ($ billion); Exhibits26: Historic Market Size - Application Segment 2019 - 2023 ($ billion); Exhibits27: Historic Market Size - Route of Administration Segment 2019 - 2023 ($ billion); Exhibits28: Historic Market Size - Method Segment 2019 - 2023 ($ billion); Exhibits29: Historic Market Size - Geography Segment 2019 - 2023 ($ billion); Exhibits30: Historic Market Size - Country Segment 2019 - 2023 ($ billion); Exhibits31: Five forces analysis - Comparison between 2024 and 2029; Exhibits32: Bargaining power of buyers - Impact of key factors 2024 and 2029; Exhibits33: Bargaining power of suppliers - Impact of key factors in 2024 and 2029; Exhibits34: Threat of new entrants - Impact of key factors in 2024 and 2029; Exhibits35: Threat of substitutes - Impact of key factors in 2024 and 2029; Exhibits36: Threat of rivalry - Impact of key factors in 2024 and 2029; Exhibits37: Chart on Market condition - Five forces 2024 and 2029; Exhibits38: Chart on Application - Market share 2024-2029 (%); Exhibits39: Data Table on Application - Market share 2024-2029 (%); Exhibits40: Chart on Comparison by Application; Exhibits41: Data Table on Comparison by Application; Exhibits42: Chart on Oncology - Market size and forecast 2024-2029 ($ billion); Exhibits43: Data Table on Oncology - Market size and forecast 2024-2029 ($ billion); Exhibits44: Chart on Oncology - Year-over-year growth 2024-2029 (%); Exhibits45: Data Table on Oncology - Year-over-year growth 2024-2029 (%); Exhibits46: Chart on Neurology - Market size and forecast 2024-2029 ($ billion); Exhibits47: Data Table on Neurology - Market size and forecast 2024-2029 ($ billion); Exhibits48: Chart on Neurology - Year-over-year growth 2024-2029 (%); Exhibits49: Data Table on Neurology - Year-over-year growth 2024-2029 (%); Exhibits50: Chart on Cardiology - Market size and forecast 2024-2029 ($ billion); Exhibits51: Data Table on Cardiology - Market size and forecast 2024-2029 ($ billion); Exhibits52: Chart on Cardiology - Year-over-year growth 2024-2029 (%); Exhibits53: Data Table on Cardiology - Year-over-year growth 2024-2029 (%); Exhibits54: Chart on Diabetes - Market size and forecast 2024-2029 ($ billion); Exhibits55: Data Table on Diabetes - Market size and forecast 2024-2029 ($ billion); Exhibits56: Chart on Diabetes - Year-over-year growth 2024-2029 (%); Exhibits57: Data Table on Diabetes - Year-over-year growth 2024-2029 (%); Exhibits58: Chart on Others - Market size and forecast 2024-2029 ($ billion); Exhibits59: Data Table on Others - Market size and forecast 2024-2029 ($ billion); Exhibits60: Chart on Others - Year-over-year growth 2024-2029 (%); Exhibits61: Data Table on Others - Year-over-year growth 2024-2029 (%); Exhibits62: Market opportunity by Application ($ billion); Exhibits63: Data Table on Market opportunity by Application ($ billion); Exhibits64: Chart on Route of Administration - Market share 2024-2029 (%); Exhibits65: Data Table on Route of Administration - Market share 2024-2029 (%); Exhibits66: Chart on Comparison by Route of Administration; Exhibits67: Data Table on Comparison by Route of Administration; Exhibits68: Chart on Oral drug delivery systems - Market size and forecast 2024-2029 ($ billion); Exhibits69: Data Table on Oral drug delivery systems - Market size and forecast 2024-2029 ($ billion); Exhibits70: Chart on Oral drug delivery systems - Year-over-year growth 2024-2029 (%); Exhibits71: Data Table on Oral drug delivery systems - Year-over-year growth 2024-2029 (%); Exhibits72: Chart on Injectable drug delivery systems - Market size and forecast 2024-2029 ($ billion); Exhibits73: Data Table on Injectable drug delivery systems - Market size and forecast 2024-2029 ($ billion); Exhibits74: Chart on Injectable drug delivery systems - Year-over-year growth 2024-2029 (%); Exhibits75: Data Table on Injectable drug delivery systems - Year-over-year growth 2024-2029 (%); Exhibits76: Chart on Pulmonary drug delivery systems - Market size and forecast 2024-2029 ($ billion); Exhibits77: Data Table on Pulmonary drug delivery systems - Market size and forecast 2024-2029 ($ billion); Exhibits78: Chart on Pulmonary drug delivery systems - Year-over-year growth 2024-2029 (%); Exhibits79: Data Table on Pulmonary drug delivery systems - Year-over-year growth 2024-2029 (%); Exhibits80: Chart on Transdermal drug delivery systems - Market size and forecast 2024-2029 ($ billion); Exhibits81: Data Table on Transdermal drug delivery systems - Market size and forecast 2024-2029 ($ billion); Exhibits82: Chart on Transdermal drug delivery systems - Year-over-year growth 2024-2029 (%); Exhibits83: Data Table on Transdermal drug delivery systems - Year-over-year growth 2024-2029 (%); Exhibits84: Chart on Others - Market size and forecast 2024-2029 ($ billion); Exhibits85: Data Table on Others - Market size and forecast 2024-2029 ($ billion); Exhibits86: Chart on Others - Year-over-year growth 2024-2029 (%); Exhibits87: Data Table on Others - Year-over-year growth 2024-2029 (%); Exhibits88: Market opportunity by Route of Administration ($ billion); Exhibits89: Data Table on Market opportunity by Route of Administration ($ billion); Exhibits90: Chart on Method - Market share 2024-2029 (%); Exhibits91: Data Table on Method - Market share 2024-2029 (%); Exhibits92: Chart on Comparison by Method; Exhibits93: Data Table on Comparison by Method; Exhibits94: Chart on Targeted drug delivery systems - Market size and forecast 2024-2029 ($ billion); Exhibits95: Data Table on Targeted drug delivery systems - Market size and forecast 2024-2029 ($ billion); Exhibits96: Chart on Targeted drug delivery systems - Year-over-year growth 2024-2029 (%); Exhibits97: Data Table on Targeted drug delivery systems - Year-over-year growth 2024-2029 (%); Exhibits98: Chart on Controlled drug delivery systems - Market size and forecast 2024-2029 ($ billion); Exhibits99: Data Table on Controlled drug delivery systems - Market size and forecast 2024-2029 ($ billion); Exhibits100: Chart on Controlled drug delivery systems - Year-over-year growth 2024-2029 (%); Exhibits101: Data Table on Controlled drug delivery systems - Year-over-year growth 2024-2029 (%); Exhibits102: Chart on Modulated drug delivery systems - Market size and forecast 2024-2029 ($ billion); Exhibits103: Data Table on Modulated drug delivery systems - Market size and forecast 2024-2029 ($ billion); Exhibits104: Chart on Modulated drug delivery systems - Year-over-year growth 2024-2029 (%); Exhibits105: Data Table on Modulated drug delivery systems - Year-over-year growth 2024-2029 (%); Exhibits106: Market opportunity by Method ($ billion); Exhibits107: Data Table on Market opportunity by Method ($ billion); Exhibits108: Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria; Exhibits109: Chart on Market share By Geographical Landscape 2024-2029 (%); Exhibits110: Data Table on Market share By Geographical Landscape 2024-2029 (%); Exhibits111: Chart on Geographic comparison; Exhibits112: Data Table on Geographic comparison; Exhibits113: Chart on North America - Market size and forecast 2024-2029 ($ billion); Exhibits114: Data Table on North America - Market size and forecast 2024-2029 ($ billion); Exhibits115: Chart on North America - Year-over-year growth 2024-2029 (%); Exhibits116: Data Table on North America - Year-over-year growth 2024-2029 (%); Exhibits117: Chart on Europe - Market size and forecast 2024-2029 ($ billion); Exhibits118: Data Table on Europe - Market size and forecast 2024-2029 ($ billion); Exhibits119: Chart on Europe - Year-over-year growth 2024-2029 (%); Exhibits120: Data Table on Europe - Year-over-year growth 2024-2029 (%); Exhibits121: Chart on Asia - Market size and forecast 2024-2029 ($ billion); Exhibits122: Data Table on Asia - Market size and forecast 2024-2029 ($ billion); Exhibits123: Chart on Asia - Year-over-year growth 2024-2029 (%); Exhibits124: Data Table on Asia - Year-over-year growth 2024-2029 (%); Exhibits125: Chart on Rest of World (ROW) - Market size and forecast 2024-2029 ($ billion); Exhibits126: Data Table on Rest of World (ROW) - Market size and forecast 2024-2029 ($ billion); Exhibits127: Chart on Rest of World (ROW) - Year-over-year growth 2024-2029 (%); Exhibits128: Data Table on Rest of World (ROW) - Year-over-year growth 2024-2029 (%); Exhibits129: Chart on US - Market size and forecast 2024-2029 ($ billion); Exhibits130: Data Table on US - Market size and forecast 2024-2029 ($ billion); Exhibits131: Chart on US - Year-over-year growth 2024-2029 (%); Exhibits132: Data Table on US - Year-over-year growth 2024-2029 (%); Exhibits133: Chart on Germany - Market size and forecast 2024-2029 ($ billion)